This page in Swedish

Carl Eriksson

Carl Eriksson Position: Adjunct Senior Lecturer School/office: School of Medical Sciences

Email: Y2FybC5lcmlrc3NvbjtvcnUuc2U=

Phone: No number available

Room: -

Carl Eriksson
Research subject

About Carl Eriksson

Carl Eriksson is a Senior Consultant in Gastroenterology and Hepatology at Örebro University Hospital and Adjunct Senior Lecturer at Örebro University. He defended his PhD thesis “Epidemiological and therapeutic aspects of inflammatory bowel disease” in 2018.

Carl’s research focuses on inflammatory bowel disease (IBD), with a particular interest in evaluating the effectiveness of new therapies such as golimumab, ustekinumab, and vedolizumab in Swedish clinical practice. Using data from the national quality register SWIBREG, he has also conducted comparative studies of treatment outcomes and contributed to advancing IBD care in Sweden.

He recently published a study confirming that IBD is associated with an increased risk of myocardial infarction, especially among patients diagnosed at age 60 or older and those with extraintestinal manifestations such as joint pain, eye inflammation, or skin symptoms. The study also demonstrated that conventional cardiovascular risk factors, including hypertension, hyperlipidemia, and diabetes, further increase the risk of myocardial infarction in patients with IBD. These findings may help guide future preventive strategies.

In the coming years, Carl plans to further explore the relationship between IBD and cardiovascular disease, as well as continue studies on the real-world effectiveness of emerging IBD therapies.

Publications

Articles in journals |  Articles, reviews/surveys |  Conference papers |  Doctoral theses, comprehensive summaries |  Manuscripts | 

Articles in journals

Articles, reviews/surveys

Conference papers

Doctoral theses, comprehensive summaries

Manuscripts